226 related articles for article (PubMed ID: 22931393)
1. BMS-708,163 targets presenilin and lacks notch-sparing activity.
Crump CJ; Castro SV; Wang F; Pozdnyakov N; Ballard TE; Sisodia SS; Bales KR; Johnson DS; Li YM
Biochemistry; 2012 Sep; 51(37):7209-11. PubMed ID: 22931393
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of selective inhibition of γ-secretase by avagacestat.
Albright CF; Dockens RC; Meredith JE; Olson RE; Slemmon R; Lentz KA; Wang JS; Denton RR; Pilcher G; Rhyne PW; Raybon JJ; Barten DM; Burton C; Toyn JH; Sankaranarayanan S; Polson C; Guss V; White R; Simutis F; Sanderson T; Gillman KW; Starrett JE; Bronson J; Sverdlov O; Huang SP; Castaneda L; Feldman H; Coric V; Zaczek R; Macor JE; Houston J; Berman RM; Tong G
J Pharmacol Exp Ther; 2013 Mar; 344(3):686-95. PubMed ID: 23275065
[TBL] [Abstract][Full Text] [Related]
3. An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.
McKee TD; Loureiro RM; Dumin JA; Zarayskiy V; Tate B
J Neurosci Methods; 2013 Feb; 213(1):14-21. PubMed ID: 23219895
[TBL] [Abstract][Full Text] [Related]
4. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
[TBL] [Abstract][Full Text] [Related]
5. Nicastrin is dispensable for gamma-secretase protease activity in the presence of specific presenilin mutations.
Futai E; Yagishita S; Ishiura S
J Biol Chem; 2009 May; 284(19):13013-22. PubMed ID: 19254953
[TBL] [Abstract][Full Text] [Related]
6. ACS chemical neuroscience molecule spotlight on BMS-708163.
Hopkins CR
ACS Chem Neurosci; 2012 Mar; 3(3):149-50. PubMed ID: 22860183
[TBL] [Abstract][Full Text] [Related]
7. Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes.
Gertsik N; Am Ende CW; Geoghegan KF; Nguyen C; Mukherjee P; Mente S; Seneviratne U; Johnson DS; Li YM
Cell Chem Biol; 2017 Jan; 24(1):3-8. PubMed ID: 28065657
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of γ-Secretase Leads to an Increase in Presenilin-1.
Sogorb-Esteve A; García-Ayllón MS; Llansola M; Felipo V; Blennow K; Sáez-Valero J
Mol Neurobiol; 2018 Jun; 55(6):5047-5058. PubMed ID: 28815510
[TBL] [Abstract][Full Text] [Related]
9. γ-Secretase modulator (GSM) photoaffinity probes reveal distinct allosteric binding sites on presenilin.
Pozdnyakov N; Murrey HE; Crump CJ; Pettersson M; Ballard TE; Am Ende CW; Ahn K; Li YM; Bales KR; Johnson DS
J Biol Chem; 2013 Apr; 288(14):9710-9720. PubMed ID: 23396974
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers.
Tong G; Wang JS; Sverdlov O; Huang SP; Slemmon R; Croop R; Castaneda L; Gu H; Wong O; Li H; Berman RM; Smith C; Albright CF; Dockens RC
Clin Ther; 2012 Mar; 34(3):654-67. PubMed ID: 22381714
[TBL] [Abstract][Full Text] [Related]
11. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.
Buggia-Prevot V; Sevalle J; Rossner S; Checler F
J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584
[TBL] [Abstract][Full Text] [Related]
12. The catalytic core of gamma-secretase: presenilin revisited.
Steiner H
Curr Alzheimer Res; 2008 Apr; 5(2):147-57. PubMed ID: 18393799
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: presenilin 2-sparing γ-secretase inhibition is a tolerable Aβ peptide-lowering strategy.
Borgegård T; Gustavsson S; Nilsson C; Parpal S; Klintenberg R; Berg AL; Rosqvist S; Serneels L; Svensson S; Olsson F; Jin S; Yan H; Wanngren J; Jureus A; Ridderstad-Wollberg A; Wollberg P; Stockling K; Karlström H; Malmberg A; Lund J; Arvidsson PI; De Strooper B; Lendahl U; Lundkvist J
J Neurosci; 2012 Nov; 32(48):17297-305. PubMed ID: 23197721
[TBL] [Abstract][Full Text] [Related]
15. Dictyostelium possesses highly diverged presenilin/gamma-secretase that regulates growth and cell-fate specification and can accurately process human APP: a system for functional studies of the presenilin/gamma-secretase complex.
McMains VC; Myre M; Kreppel L; Kimmel AR
Dis Model Mech; 2010; 3(9-10):581-94. PubMed ID: 20699477
[TBL] [Abstract][Full Text] [Related]
16. Presenilins and the gamma-secretase: still a complex problem.
Small DH; Klaver DW; Foa L
Mol Brain; 2010 Feb; 3():7. PubMed ID: 20181106
[TBL] [Abstract][Full Text] [Related]
17. Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways.
Duggan SP; McCarthy JV
Cell Signal; 2016 Jan; 28(1):1-11. PubMed ID: 26498858
[TBL] [Abstract][Full Text] [Related]
18. Second generation γ-secretase modulators exhibit different modulation of Notch β and Aβ production.
Wanngren J; Ottervald J; Parpal S; Portelius E; Strömberg K; Borgegård T; Klintenberg R; Juréus A; Blomqvist J; Blennow K; Zetterberg H; Lundkvist J; Rosqvist S; Karlström H
J Biol Chem; 2012 Sep; 287(39):32640-50. PubMed ID: 22851182
[TBL] [Abstract][Full Text] [Related]
19. Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases.
Wolfe MS
Biol Chem; 2010 Aug; 391(8):839-47. PubMed ID: 20482315
[TBL] [Abstract][Full Text] [Related]
20. Substrate-targeting gamma-secretase modulators.
Kukar TL; Ladd TB; Bann MA; Fraering PC; Narlawar R; Maharvi GM; Healy B; Chapman R; Welzel AT; Price RW; Moore B; Rangachari V; Cusack B; Eriksen J; Jansen-West K; Verbeeck C; Yager D; Eckman C; Ye W; Sagi S; Cottrell BA; Torpey J; Rosenberry TL; Fauq A; Wolfe MS; Schmidt B; Walsh DM; Koo EH; Golde TE
Nature; 2008 Jun; 453(7197):925-9. PubMed ID: 18548070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
